SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001601485-23-000028
Filing Date
2023-04-28
Accepted
2023-04-28 16:33:11
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A angn-20221231.htm   iXBRL 10-K/A 161511
2 EX-31.3 ex313_angnx123122-10k.htm EX-31.3 5802
3 EX-31.4 ex314_angnx123122x10k.htm EX-31.4 5606
4 EX-32.2 ex322_angnx123122-10ka.htm EX-32.2 4253
  Complete submission text file 0001601485-23-000028.txt   407610

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20221231.xsd EX-101.SCH 1890
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20221231_lab.xml EX-101.LAB 39579
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20221231_pre.xml EX-101.PRE 20994
9 EXTRACTED XBRL INSTANCE DOCUMENT angn-20221231_htm.xml XML 19466
Mailing Address 7-57 WELLS AVENUE NEWTON MA 02459
Business Address 7-57 WELLS AVENUE NEWTON MA 02459 (857) 336-4001
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39990 | Film No.: 23867146
SIC: 2834 Pharmaceutical Preparations